117 related articles for article (PubMed ID: 24796884)
1. Investigation of amino acid conjugates of (S)-1-[1-(4-aminobenzoyl)-2,3-dihydro-1H-indol-6-sulfonyl]-4-phenyl-imidazolidin-2-one (DW2282) as water soluble anticancer prodrugs.
Lee KC; Venkateswararao E; Sharma VK; Jung SH
Eur J Med Chem; 2014 Jun; 80():439-46. PubMed ID: 24796884
[TBL] [Abstract][Full Text] [Related]
2. A novel stereo-selective sulfonylurea, 1-[1-(4-aminobenzoyl)-2,3-dihydro-1H-indol-6-sulfonyl]-4-phenyl-imidazolidin-2-one, has antitumor efficacy in in vitro and in vivo tumor models.
Lee CW; Hong DH; Han SB; Jung SH; Kim HC; Fine RL; Lee SH; Kim HM
Biochem Pharmacol; 2002 Aug; 64(3):473-80. PubMed ID: 12147299
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the anticancer activity of DW2282, a new anticancer agent.
Hwang HS; Moon EY; Seong SK; Choi CH; Chung YH; Jung SH; Lee DK; Yoon SJ
Anticancer Res; 1999; 19(6B):5087-93. PubMed ID: 10697515
[TBL] [Abstract][Full Text] [Related]
4. Water soluble prodrugs of the antitumor agent 3-[(3-amino-4-methoxy)phenyl]-2-(3,4,5-trimethoxyphenyl)cyclopent-2-ene-1-one.
Nam NH; Kim Y; You YJ; Hong DH; Kim HM; Ahn BZ
Bioorg Med Chem; 2003 Mar; 11(6):1021-9. PubMed ID: 12614888
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
Devkota L; Lin CM; Strecker TE; Wang Y; Tidmore JK; Chen Z; Guddneppanavar R; Jelinek CJ; Lopez R; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem; 2016 Mar; 24(5):938-956. PubMed ID: 26852340
[TBL] [Abstract][Full Text] [Related]
6. Effect of DW2282 on the induction of methemoglobinemia, hypoglycemia or WBC count and hematological changes.
Moon EY; Hwang HS; Choi CH; Jung SH; Yoon SJ
Arch Pharm Res; 1999 Dec; 22(6):565-70. PubMed ID: 10615861
[TBL] [Abstract][Full Text] [Related]
7. Quercetin-Amino Acid Conjugates are Promising Anti-Cancer Agents in Drug Discovery Projects.
Dobrydnev AV; Tkachuk TM; Atamaniuk VP; Popova MV
Mini Rev Med Chem; 2020; 20(2):107-122. PubMed ID: 31595850
[TBL] [Abstract][Full Text] [Related]
8. Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
Fang L; Wang M; Gou S; Liu X; Zhang H; Cao F
J Med Chem; 2014 Feb; 57(3):1116-20. PubMed ID: 24422538
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and in vitro efficacy of O-carboxymethyl chitosan conjugate of melphalan.
Lu B; Huang D; Zheng H; Huang Z; Xu P; Xu H; Yin Y; Liu X; Li D; Zhang X
Carbohydr Polym; 2013 Oct; 98(1):36-42. PubMed ID: 23987314
[TBL] [Abstract][Full Text] [Related]
10. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
Jain M; Fan J; Baturay NZ; Kwon CH
J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
[TBL] [Abstract][Full Text] [Related]
11. Design and Synthesis of Polymer Prodrugs for Improving Water-Solubility, Pharmacokinetic Behavior and Antitumor Efficacy of TXA9.
Li Y; Ye C; Cai C; Zhao M; Han N; Liu Z; Zhai J; Yin J
Pharm Res; 2020 Mar; 37(3):66. PubMed ID: 32166420
[TBL] [Abstract][Full Text] [Related]
12. Water-soluble prodrugs of an Aurora kinase inhibitor.
Oslob JD; Heumann SA; Yu CH; Allen DA; Baskaran S; Bui M; Delarosa E; Fung AD; Hashash A; Hau J; Ivy S; Jacobs JW; Lew W; Maung J; McDowell RS; Ritchie S; Romanowski MJ; Silverman JA; Yang W; Zhong M; Fuchs-Knotts T
Bioorg Med Chem Lett; 2009 Mar; 19(5):1409-12. PubMed ID: 19186057
[TBL] [Abstract][Full Text] [Related]
13. EB1627: a soluble prodrug of the potent anticancer cyanoguanidine CHS828.
Binderup E; Björkling F; Hjarnaa PV; Latini S; Baltzer B; Carlsen M; Binderup L
Bioorg Med Chem Lett; 2005 May; 15(10):2491-4. PubMed ID: 15863303
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of water-soluble etoposide esters of malic acid as prodrugs.
Chen J; Du W
Med Chem; 2013 Aug; 9(5):740-7. PubMed ID: 23061567
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of anticancer activity of BOC26P, an ortho-aryl chalcone sodium phosphate as water-soluble prodrugs in vitro and in vivo.
Zhu C; Wang R; Zheng W; Chen D; Yue X; Cao Y; Qin W; Sun H; Wang Y; Liu Z; Li B; Du J; Bu X; Zhou B
Biomed Pharmacother; 2017 Dec; 96():551-562. PubMed ID: 29032339
[TBL] [Abstract][Full Text] [Related]
16. Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers.
Zhao H; Rubio B; Sapra P; Wu D; Reddy P; Sai P; Martinez A; Gao Y; Lozanguiez Y; Longley C; Greenberger LM; Horak ID
Bioconjug Chem; 2008 Apr; 19(4):849-59. PubMed ID: 18370417
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins.
Ohsumi K; Hatanaka T; Nakagawa R; Fukuda Y; Morinaga Y; Suga Y; Nihei Y; Ohishi K; Akiyama Y; Tsuji T
Anticancer Drug Des; 1999 Dec; 14(6):539-48. PubMed ID: 10834274
[TBL] [Abstract][Full Text] [Related]
18. In vitro solubility, stability and permeability of novel quercetin-amino acid conjugates.
Kim MK; Park KS; Yeo WS; Choo H; Chong Y
Bioorg Med Chem; 2009 Feb; 17(3):1164-71. PubMed ID: 19128975
[TBL] [Abstract][Full Text] [Related]
19. An improved design of water-soluble propofol prodrugs characterized by rapid onset of action.
Lang BC; Yang J; Wang Y; Luo Y; Kang Y; Liu J; Zhang WS
Anesth Analg; 2014 Apr; 118(4):745-54. PubMed ID: 24651228
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines.
Monteiro AS; Almeida J; Cabral G; Severino P; Videira PA; Sousa A; Nunes R; Pereira JD; Francisco AP; Perry MJ; Mendes E
Eur J Med Chem; 2013; 70():1-9. PubMed ID: 24125877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
